BioNTech SE reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was EUR 6,362.2 million compared to EUR 2,027.5 million a year ago. Revenue was EUR 6,374.6 million compared to EUR 2,048.4 million a year ago. Net income was EUR 3,698.8 million compared to EUR 1,128.1 million a year ago. Basic earnings per share from continuing operations was EUR 15.13 compared to EUR 4.64 a year ago. Diluted earnings per share from continuing operations was EUR 14.24 compared to EUR 4.39 a year ago.